Ishihara Sangyo Kaisha (4028) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Nov, 2025Executive summary
Net sales for the six months ended September 30, 2024, increased by 10.4% year-over-year to ¥74,522 million.
Operating income rose 16.4% to ¥2,653 million, but net income dropped 80.6% to ¥727 million compared to the same period last year.
Comprehensive income decreased 51.4% year-over-year to ¥2,895 million.
Financial highlights
Gross profit increased to ¥16,906 million from ¥14,975 million year-over-year.
Ordinary income fell 55.0% to ¥2,486 million.
Net income per share was ¥19.03, down from ¥98.24 in the prior year.
Cash and deposits rose to ¥26,268 million from ¥19,982 million at the previous fiscal year-end.
Cash flows from operating activities surged to ¥18,245 million from ¥3,367 million year-over-year.
Outlook and guidance
Full-year net sales are forecast at ¥148,000 million, up 6.9% year-over-year.
Operating income is projected to decline 13.0% to ¥10,000 million, and net income to fall 24.9% to ¥6,000 million.
Annual dividend forecast is ¥70.00 per share, unchanged from the previous year.
Latest events from Ishihara Sangyo Kaisha
- Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Net sales up 4.9% year-over-year, with profit and dividend growth forecast for FY2026.4028
Q4 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025 - Operating profit and net income surged, with robust outlook and higher full-year forecasts.4028
Q2 202620 Nov 2025